TIVC Form 4: Director Zikria Dean receives 7,500 stock options

Rhea-AI Filing Summary

Tivic Health Systems director Zikria Dean was granted a stock option to purchase 7,500 shares of common stock on 08/06/2025 at an exercise price of $3.32. The option vests in four equal quarterly installments, with 100% vesting upon the first anniversary of the grant, and expires on 08/05/2035. Following the reported transaction the reporting person directly beneficially owns 7,500 derivative securities representing the right to acquire 7,500 shares.

This Form 4 reports a non-cash equity award to an insider: the grant establishes the right to purchase common stock at a fixed price and details the vesting timetable and expiration date.

Positive

• Grant of 7,500 stock options to a director is explicitly disclosed
• Exercise price documented at $3.32, providing clear terms
• Vesting schedule specified: four equal quarterly installments with full vesting by first anniversary
• Expiration date provided: 08/05/2035, clarifying option term

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Director received a time‑based option grant of 7,500 shares with full vesting within one year; routine insider compensation disclosure.

The Form 4 documents a standard director equity award: a stock option with an exercise price of $3.32 covering 7,500 shares, vesting in four equal quarterly installments and fully vested by the first anniversary. The option expires on 08/05/2035 and is reported as directly beneficially owned following the acquisition. From a governance perspective this is a routine disclosure that clarifies insider holdings and the schedule under which equity becomes exercisable.

Securities Analyst

TL;DR: 7,500 options at $3.32 granted to a director; the economical impact depends on company share count and future stock performance.

The filing shows an acquisition coded as an option grant (Transaction Code A) for 7,500 stock options with a $3.32 exercise price, exercisable per the stated quarterly vesting schedule and expiring in 2035. The report confirms direct beneficial ownership of 7,500 derivative securities after the grant. The document provides the core terms investors use to model potential dilution and future insider exercise scenarios, but does not include share count or pro forma dilution figures.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zikria Dean

(Last) (First) (Middle)

47685 LAKEVIEW BOULEVARD

(Street)

FREMONT CA 94538

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Tivic Health Systems, Inc. [ TIVC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Purchase)	$3.32	08/06/2025		A		7,500		(1)	08/05/2035	Common Stock	7,500	$0.00	7,500	D

Explanation of Responses:

1. The stock option vests in a series of four (4) successive equal quarterly installments, rounded downward to the nearest whole share, measured from the grant date, such that 100% of the stock option will be vested upon the first anniversary of the grant date.

	/s/ Jennifer Ernst, attorney-in-fact	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Tivic Health (TIVC) report in this Form 4?

The filing reports that director Zikria Dean was granted a stock option to acquire 7,500 shares, with an exercise price of $3.32 on 08/06/2025.

How does the option vest for the grant reported by TIVC?

The option vests in four equal quarterly installments, rounded down to whole shares, such that 100% vests at the one-year anniversary of the grant.

When does the option expire and how many shares underlie it?

The option expires on 08/05/2035 and is exercisable for 7,500 shares of common stock.

What is the ownership form reported for the derivative securities?

The filing reports the derivative securities as Direct (D) beneficial ownership following the reported transaction.

What transaction code and type are shown on the Form 4 for this grant?

The transaction is coded as A (acquisition) and the derivative security type is listed as Stock Option (Right to Purchase).